0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report & Forecast 2022-2028
Published Date: April 2022
|
Report Code: QYRE-Auto-5X8306
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
United States Dipeptidyl Peptidase IV DPP IV Inhibitors Market Report Forecast 2021 2027

Global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Report & Forecast 2022-2028

Code: QYRE-Auto-5X8306
Report
April 2022
95 Pages
QYResearch
Region: United States,
Description
Table of Content
Tables & Figures
Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs. Also known as gliptins, they are usually prescribed for people with type 2 diabetes who have not responded well to drugs such as metformin and sulphonylureas
Market Analysis and Insights: Global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
This report focuses on global and United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Sitagliptin accounting for % of the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Scope and Market Size
Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others

Segment by Application

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

BY COMPANY

AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda
1 Study Coverage
1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Introduction
1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Outlook 2017 VS 2022 VS 2028
1.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in US$ Million for the Year 2017-2028
1.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume for the Year 2017-2028
1.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Outlook 2017 VS 2022 VS 2028
1.3.1 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in US$ Million for the Year 2017-2028
1.3.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume for the Year 2017-2028
1.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Dynamics
1.5.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends
1.5.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
1.5.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
1.5.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment by Type
2.1.1 Sitagliptin
2.1.2 Vildagliptin
2.1.3 Saxagliptin
2.1.4 Linagliptin
2.1.5 Others
2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
2.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
2.3.1 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
3.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
3.3.1 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Competitor Landscape by Company
4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Company
4.1.1 Top Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Ranked by Revenue (2021)
4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer (2017-2022)
4.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer (2017-2022)
4.1.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Manufacturer (2017-2022)
4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Concentration Ratio (CR)
4.2.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in 2021
4.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturing Base Distribution, Product Type
4.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Type
4.3.3 Date of International Manufacturers Enter into Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Company
4.5.1 Top Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players in United States, Ranked by Revenue (2021)
4.5.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Players (2020, 2021 & 2022)
5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region
5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size in Volume by Region (2017-2028)
5.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region: 2017-2022
5.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Forecast by Region (2023-2028)
5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size in Value by Region (2017-2028)
5.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region: 2017-2022
5.3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size YoY Growth 2017-2028
6.1.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size YoY Growth 2017-2028
6.3.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size YoY Growth 2017-2028
6.4.2 Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporation Information
7.1.2 AstraZeneca Description and Business Overview
7.1.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.1.5 AstraZeneca Recent Development
7.2 Boehringer
7.2.1 Boehringer Corporation Information
7.2.2 Boehringer Description and Business Overview
7.2.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.2.5 Boehringer Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Corporation Information
7.3.2 Eli Lilly Description and Business Overview
7.3.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.3.5 Eli Lilly Recent Development
7.4 Merck
7.4.1 Merck Corporation Information
7.4.2 Merck Description and Business Overview
7.4.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.4.5 Merck Recent Development
7.5 Mitsubishi Tanabe Pharma
7.5.1 Mitsubishi Tanabe Pharma Corporation Information
7.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
7.5.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.5.5 Mitsubishi Tanabe Pharma Recent Development
7.6 Novartis
7.6.1 Novartis Corporation Information
7.6.2 Novartis Description and Business Overview
7.6.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.6.5 Novartis Recent Development
7.7 Takeda
7.7.1 Takeda Corporation Information
7.7.2 Takeda Description and Business Overview
7.7.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Products Offered
7.7.5 Takeda Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Chain Analysis
8.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
8.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process
8.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales and Marketing
8.4.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Channels
8.4.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
8.5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Trends
    Table 3. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Drivers
    Table 4. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Challenges
    Table 5. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Restraints
    Table 6. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Manufacturer, 2017-2022
    Table 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase IV (DPP-IV) Inhibitors as of 2021)
    Table 18. Top Players of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Type
    Table 20. Date of International Manufacturers Enter into Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AstraZeneca Corporation Information
    Table 43. AstraZeneca Description and Business Overview
    Table 44. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product
    Table 46. AstraZeneca Recent Development
    Table 47. Boehringer Corporation Information
    Table 48. Boehringer Description and Business Overview
    Table 49. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Boehringer Product
    Table 51. Boehringer Recent Development
    Table 52. Eli Lilly Corporation Information
    Table 53. Eli Lilly Description and Business Overview
    Table 54. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Eli Lilly Product
    Table 56. Eli Lilly Recent Development
    Table 57. Merck Corporation Information
    Table 58. Merck Description and Business Overview
    Table 59. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Merck Product
    Table 61. Merck Recent Development
    Table 62. Mitsubishi Tanabe Pharma Corporation Information
    Table 63. Mitsubishi Tanabe Pharma Description and Business Overview
    Table 64. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Mitsubishi Tanabe Pharma Product
    Table 66. Mitsubishi Tanabe Pharma Recent Development
    Table 67. Novartis Corporation Information
    Table 68. Novartis Description and Business Overview
    Table 69. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Novartis Product
    Table 71. Novartis Recent Development
    Table 72. Takeda Corporation Information
    Table 73. Takeda Description and Business Overview
    Table 74. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Takeda Product
    Table 76. Takeda Recent Development
    Table 77. Key Raw Materials Lists
    Table 78. Raw Materials Key Suppliers Lists
    Table 79. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List
    Table 80. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Picture
    Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 4. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2017-2028 (K MT)
    Figure 5. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size 2017-2028 (US$ Million)
    Figure 7. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales 2017-2028 (K MT)
    Figure 8. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Report Years Considered
    Figure 11. Product Picture of Sitagliptin
    Figure 12. Product Picture of Vildagliptin
    Figure 13. Product Picture of Saxagliptin
    Figure 14. Product Picture of Linagliptin
    Figure 15. Product Picture of Others
    Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type in 2022 & 2028
    Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2017-2028) & (K MT)
    Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2017-2028) & (USD/MT)
    Figure 22. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Type in 2022 & 2028
    Figure 23. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2017-2028) & (K MT)
    Figure 26. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2017-2028) & (USD/MT)
    Figure 28. Product Picture of Hospital Pharmacies
    Figure 29. Product Picture of Retail Pharmacies
    Figure 30. Product Picture of Online Pharmacies
    Figure 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application in 2022 & 2028
    Figure 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2017-2028) & (K MT)
    Figure 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2017-2028) & (USD/MT)
    Figure 37. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Share by Application in 2022 & 2028
    Figure 38. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2017-2028) & (K MT)
    Figure 41. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2017-2028) & (USD/MT)
    Figure 43. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 44. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 48. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 55. Asia-Pacific Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 67. Latin America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 72. Middle East & Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. UAE Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain
    Figure 77. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sitagliptin Phosphate API Market Research Report 2022
Global Sitagliptin Phosphate API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-20U11672
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Wearable Blood Glucose Meter Market Research Report 2022
Global Wearable Blood Glucose Meter Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-25N11464
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Laboratory Blood Glucose Analyzers Market Research Report 2022
Global Laboratory Blood Glucose Analyzers Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-36B11563
Mon Aug 08 00:00:00 UTC 2022

Add to Cart

Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2022
Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-24T11037
Sun Aug 07 00:00:00 UTC 2022

Add to Cart